| DENTAL AND OPHTHALMICS CD |
| Permanent storage and easy retrieval of Journal articles and formulations. |
| Only $95 per CD. |
| (Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.) |
 |
- Print Journal articles in color from the pdf file for your marketing needs.
- Eliminate long searches through past issues for articles and formulations.
|
| This CD contains the following articles listed by volume, issue and page number: |
| DENTAL RELATED ARTICLES |
| Title | Volume/Issue | Page |
| A Review of Stomatitis and Treatment in Cats |
Vol. 13 No. 5 |
372 |
| Lidocaine 10% Oral Pluronic Lecithin Organogel |
Vol. 13 No. 5 |
433 |
| Lidocaine 2% Popsicle |
Vol. 13 No. 3 |
242 |
| Electrolyte Lollipop (Adult) |
Vol. 13 No. 1 |
70 |
| Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse |
Vol. 13 No. 1 |
71 |
| Tetracaine 0.025% Popsicles |
Vol. 13 No. 1 |
73 |
| Dichlorobenzyl Alcohol Tooth Gel |
Vol. 12 No. 5 |
449 |
| Potassium Nitrate/Benzocaine/Tetracaine Dental Gel |
Vol. 12 No. 3 |
266 |
| Miconazole 2% Oral Gel |
Vol. 11 No. 6 |
512 |
| Mebeverine Hydrochloride 20% gel |
Vol. 11 No. 4 |
330 |
| Basics of Compounding for Dentistry, Part 2: Tooth Whitening |
Vol. 10 No. 3 |
205 |
| Triamcinolone Acetonide 0.1% Mouthwash Solution |
Vol. 10 No. 3 |
229 |
| Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations |
Vol. 10 No. 2 |
122 |
| BMS Mouthwash |
Vol. 9 No. 4 |
310 |
| Burow's Solution |
Vol. 9 No. 4 |
314 |
| Whitehead's Varnish |
Vol. 9 No. 4 |
319 |
| Capsaicin 0.2-mg Troches |
Vol. 9 No. 2 |
148 |
| Clobetasol and Dyclonine Oral Paste |
Vol. 9 No. 2 |
150 |
| Compounding for the Dental Patient: A Focus on Ulcers of the Mouth |
Vol. 8 No. 6 |
436 |
| Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications |
Vol. 8 No. 5 |
337 |
| Stomatitis Mouthwash |
Vol. 8 No. 2 |
140 |
| Women's Oral Health: Is There a Hormonal Link? |
Vol. 8 No. 1 |
10 |
| Astringent Mouthwash |
Vol. 6 No. 2 |
105 |
| Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh |
Vol. 6 No. 1 |
16 |
| Benzocaine 2% Sorbitol Antigag Candy |
Vol. 6 No. 1 |
17 |
| Tetracycline 5%, Dexamethasone 0.2% Periodontal Gel |
Vol. 6 No. 1 |
17 |
| Fluoride 0.25-mg Sugar-Free Hard Candy |
Vol. 6 No. 1 |
17 |
| Compounding in History: Dental Considerations |
Vol. 6 No. 1 |
32 |
| Toothpowder |
Vol. 6 No. 1 |
33 |
| Liquid Dentifrice |
Vol. 6 No. 1 |
33 |
| Toothache Wax |
Vol. 6 No. 1 |
33 |
| Veterinary Oral Pastes |
Vol. 5 No. 2 |
135 |
| Clinical Management and Review of Sjogren's Syndrome |
Vol. 4 No. 5 |
338 |
| Sodium Fluoride Gel (0.5% Fluoride) |
Vol. 4 No. 5 |
339 |
| Clotrimazole 10 mg Base A Troche |
Vol. 4 No. 5 |
339 |
| Saliva Substitute |
Vol. 4 No. 5 |
340 |
| Pilocarpine HCl 2-mg Troches |
Vol. 4 No. 5 |
381 |
| Xerostomia |
Vol. 4 No. 3 |
176 |
| Misoprostol 0.001% and Lidocaine 0.5% Oral Rinse |
Vol. 4 No. 3 |
211 |
| Misoprostol 0.0027% Mucoadhesive Powder |
Vol. 4 No. 3 |
212 |
| Saliva Substitute for Dry Mouth/Throat |
Vol. 4 No. 3 |
215 |
| Stomatitis Preparations |
Vol. 4 No. 3 |
216 |
| Chlorhexidine 0.2% Oral Rinse |
Vol. 4 No. 2 |
128 |
| Issues and Opportunities: Compounding for Dentistry |
Vol. 3 No. 1 |
4 |
| Compounding Mouthwashes and Rinses for Oral Ulcerations |
Vol. 3 No. 1 |
8 |
| Mouthwash/Gargle Formulation No. 1 |
Vol. 3 No. 1 |
12 |
| Mouthwash/Gargle Formulation No. 2 |
Vol. 3 No. 1 |
12 |
| Mouthwash/Gargle Formulation No. 3 |
Vol. 3 No. 1 |
12 |
| Toothgel Vehicle |
Vol. 3 No. 1 |
13 |
| Toothpaste Vehicle |
Vol. 3 No. 1 |
13 |
| Mouthwash, Toothpaste and Toothgel Vehicles |
Vol. 3 No. 1 |
12 |
| Toxicity of Amalgams |
Vol. 3 No. 1 |
14 |
| Brief Look at the History of Oral Hygiene, A |
Vol. 3 No. 1 |
17 |
| Dental Compounding in Denmark |
Vol. 3 No. 1 |
18 |
| Dental Cavity Varnish |
Vol. 3 No. 1 |
42 |
| Dental Chemical Curettage Agent |
Vol. 3 No. 1 |
43 |
| Dental Pressure Indicating Paste (PIP) |
Vol. 3 No. 1 |
44 |
| Fluoride Lozenges |
Vol. 3 No. 1 |
45 |
| Gag Tablet |
Vol. 3 No. 1 |
46 |
| Gum Massage Gel |
Vol. 3 No. 1 |
47 |
| Misoprostol 0.0024% and Lidocaine 1% in Glycerin Mouth Paint |
Vol. 3 No. 1 |
48 |
| Misoprostol Mucoadhesive Anesthetic Powder |
Vol. 3 No. 1 |
49 |
| Potassium Nitrate Desensitizing Gel |
Vol. 3 No. 1 |
50 |
| Tetracycline 2.4% or Metronidazole 10% Periodontal Gel |
Vol. 3 No. 1 |
51 |
| OPHTHALMICS RELATED ARTICLES |
| Title | Volume/Issue | Page |
| Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis |
Vol. 13 No. 6 |
506 |
| Calculations |
Vol. 13 No. 6 |
545 |
| Cidofovir 0.2-mg/mL Intravitreous Injection |
Vol. 13 No. 6 |
554 |
| Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops |
Vol. 13 No. 6 |
540 |
| Miconazole 1% Ophthalmic Solution, Veterinary |
Vol. 13 No. 6 |
559 |
| Voriconazole 2% Ophthalmic Solution |
Vol. 13 No. 6 |
562 |
| Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes |
Vol. 13 No. 6 |
564 |
| Testing the Long-Term Stability of Vancomycin Ophthalmic Solution |
Vol. 12 No. 5 |
456 |
| Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration |
Vol. 12 No. 1 |
8 |
| Calculations: High-Technology Compounding and Investigational Dispensing |
Vol. 11 No. 6 |
500 |
| Interferon alfa-2b Ophthalmic Solution |
Vol. 11 No. 6 |
510 |
| Carbidopa 1.25-mg/mL Oral Liquid |
Vol. 11 No. 1 |
70 |
| Compounding for Feline Herpetic Keratitis |
Vol. 10 No. 6 |
411 |
| Standard Operating Procedure: Sterility Test for Ophthalmic Solutions |
Vol. 10 No. 3 |
218 |
| Book and Literature Reviews |
Vol. 8 No. 5 |
324 |
| Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 |
Vol. 8 No. 5 |
359 |
| Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 |
Vol. 8 No. 4 |
277 |
| Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 |
Vol. 8 No. 3 |
169 |
| Amphotericin B 2-mg/mL Ophthalmic Solution |
Vol. 8 No. 3 |
185 |
| Fluorouracil 1% Ophthalmic Solution |
Vol. 8 No. 3 |
217 |
| Netilmicin 0.455% Ophthalmic Solution |
Vol. 8 No. 2 |
138 |
| Bacitracin 500-U/g Ophthalmic Ointment |
Vol. 7 No. 6 |
467 |
| Chloramphenicol 0.5% Ophthalmic Solution |
Vol. 7 No. 6 |
468 |
| Dexamethasone Phosphate 0.05% Ophthalmic Ointment |
Vol. 7 No. 3 |
215 |
| Epinephrine Bitartrate 2% Ophthalmic Solution |
Vol. 7 No. 3 |
218 |
| Erythromycin and Dexamethasone Ophthalmic Solution |
Vol. 6 No. 6 |
452 |
| Cefazolin Ophthalmic Solution, USP 0.35- mg/mL |
Vol. 5 No. 4 |
300 |
| Cyclopentolate HCl 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution |
Vol. 5 No. 4 |
301 |
| Hyaluronidase Injection |
Vol. 5 No. 4 |
303 |
| Phenylephrine 0.25% Ophthalmic Solution, Preservative Free |
Vol. 5 No. 4 |
307 |
| Tissue Plasminogen Activator (TPA) 25-mcg/100-mcL Ophthalmic Solution |
Vol. 5 No. 4 |
309 |
| Mitomycin 0.02% Ophthalmic Solution |
Vol. 5 No. 3 |
209 |
| Tetracycline HCl 1% Ophthalmic Ointment |
Vol. 5 No. 3 |
212 |
| Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution |
Vol. 5 No. 3 |
213 |
| Artificial Tears for Dry Eyes |
Vol. 4 No. 5 |
376 |
| Interferon Ophthalmic Solution |
Vol. 4 No. 5 |
380 |
| Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution |
Vol. 4 No. 4 |
320 |
| Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution |
Vol. 4 No. 2 |
146 |
| Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution |
Vol. 3 No. 4 |
316 |
| Compounding Ophthalmic Preparations |
Vol. 2 No. 3 |
184 |
| Isotonic Sodium Chloride Solution Vehicle for Ophthalmics |
Vol. 2 No. 3 |
188 |
| Boric Acid Solution Vehicle for Ophthalmic Preparations |
Vol. 2 No. 3 |
188 |
| Boric Acid Solution Vehicle without Benzalkonium Chloride for Ophthmalic Preparations |
Vol. 2 No. 3 |
188 |
| Phosphate Buffer System Vehicle for Ophthalmics |
Vol. 2 No. 3 |
188 |
| Ophthalmic Compounding: Techniques for Achieving Sterility |
Vol. 2 No. 3 |
189 |
| Buffer Solutions for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
| Palitzsch Buffer Acid Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
| Sodium Acetate-Boric Acid-Alkaline Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
| Sorensen's Modified Phosphate Buffer-Acid Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
| Sorensen's Modified Phosphate Buffer- Alkaline Stock Solution for Ophthalmic Preparations |
Vol. 2 No. 3 |
190 |
| Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Acid Stock Solution |
Vol. 2 No. 3 |
190 |
| Atkins and Pantin Buffer Solution for Ophthalmic Preparations - Alkaline Stock Solution |
Vol. 2 No. 3 |
190 |
| Feldman Buffer for Ophthalmic Preparations-Acid Stock Solution |
Vol. 2 No. 3 |
190 |
| Feldman Buffer for Ophthalmic Preparations-Alkaline Stock Solution |
Vol. 2 No. 3 |
190 |
| Gilford Ophthalmic Buffer-Acid Stock Solution |
Vol. 2 No. 3 |
191 |
| Gilford Ophthalmic Buffer-Alkaline Stock Solution |
Vol. 2 No. 3 |
191 |
| Anatomy of the Eye |
Vol. 2 No. 3 |
191 |
| Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations |
Vol. 2 No. 3 |
192 |
| Ophthalmic Solutions in Cataract Surgery |
Vol. 2 No. 3 |
196 |
| Veterinary Dexamethasone 0.1% Ophthalmic Ointment |
Vol. 2 No. 3 |
206 |
| Veterinary 2-deoxy-D-glucose Ophthalmic Ointment |
Vol. 2 No. 3 |
206 |
| Ophthalmic Compounding for Animals - Equine Ophthalmic Ointments and Treatment of Epithelial Calcification of the Cornea with EDTA 1% |
Vol. 2 No. 3 |
206 |
| Eyecups: The Beginning of Eye Irrigation and Treatment |
Vol. 2 No. 3 |
208 |
| Acetylcysteine 15% Ophthalmic Solution |
Vol. 2 No. 3 |
222 |
| Amphotericin B 2-mg/mL Ophthalmic Solution |
Vol. 2 No. 3 |
223 |
| Ascorbic Acid 10% Ophthalmic Solution |
Vol. 2 No. 3 |
224 |
| Calcium Gluconate 1% Ophthalmic Irrigation Solution |
Vol. 2 No. 3 |
225 |
| Cyclosporine 2% Ophthalmic Solution |
Vol. 2 No. 3 |
226 |
| Dexamethasone Sodium Phosphate 0.05% Ophthalmic Ointment |
Vol. 2 No. 3 |
227 |
| Fluconazole 0.2% Ophthalmic Solution |
Vol. 2 No. 3 |
228 |
| Fortified Gentamicin Ophthalmic Solution |
Vol. 2 No. 3 |
229 |
| Glucose 40% Ophthalmic Ointment |
Vol. 2 No. 3 |
230 |
| Idoxuridine 0.5% Ophthalmic Ointment |
Vol. 2 No. 3 |
231 |
| Idoxuridine 0.1% Ophthalmic Solution |
Vol. 2 No. 3 |
232 |
| Lissamine Green 0.5% Ophthalmic Solution |
Vol. 2 No. 3 |
233 |
| Ophthalmic Lubricant |
Vol. 2 No. 3 |
234 |
| Rose Bengal 1% Ophthalmic Solution |
Vol. 2 No. 3 |
235 |
| Vancomycin 25-mg/mL Ophthalmic Solution |
Vol. 2 No. 3 |
236 |
| Sorption of Benzalkonium Chloride to Various Filters Used in Ophthalmics |
Vol. 2 No. 3 |
249 |
| Acetylcysteine 10% Ophthalmic Solution |
Vol. 1 No. 5 |
320 |
| Tropicamide-Hydroxyamphetamine Hydrobromide Ophthalmic Solution |
Vol. 1 No. 5 |
335 |